Insight Molecular DiagnosticIMDX
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 35 institutions reported holding Insight Molecular Diagnostic (IMDX) in their 13F filings, up 8 from Q3 2025. 9 opened new positions and 1 sold out. The largest holders were Broadwood Capital Inc. ($85.6M), AWM Investment Company, Inc. ($21.1M) and Pura Vida Investments, LLC ($7.1M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Insight Molecular Diagnostic
- CUSIP
- 68235C206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $2.1M |
| Exits | 1 | $10 |
All 13F filers, Q3 2025 → Q4 2025: 438,416 shares bought and 69,690 shares sold, net +368,726 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Broadwood Capital Inc. | 5.17% | No change | 11,410,100 | $85.6M |
| AWM Investment Company, Inc. | 2.04% | Reduce -0.3% | 2,814,230 | $21.1M |
| Pura Vida Investments, LLC | 26.55% | No change | 947,134 | $7.1M |
| Vanguard Group Inc. | 0.00% | Add +8.2% | 526,675 | $4.0M |
| Geode Capital Management, LLC | 0.00% | Add +16.4% | 230,971 | $1.7M |
| BlackRock, Inc. | 0.00% | Add +49.4% | 131,361 | $985K |
| 683 Capital Management, LLC | 0.05% | New | 77,204 | $579K |
| Susquehanna International Group, LLP | 0.00% | New | 72,451 | $543K |
| Millennium Management | 0.00% | Reduce -16.3% | 61,377 | $460K |
| Northern Trust Corp. | 0.00% | Add +48.5% | 48,858 | $366K |
| State Street Corp. | 0.00% | Add +14.1% | 47,754 | $358K |
| Jane Street Group, LLC | 0.00% | New | 42,469 | $319K |
| FNY Investment Advisers, LLC | 0.09% | Reduce -23.5% | 40,584 | $304K |
| Morgan Stanley | 0.00% | Reduce -42.3% | 35,913 | $269K |
| Qube Research & Technologies Ltd | 0.00% | New | 28,351 | $213K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 26,164 | $196K |
| Osaic Holdings, Inc. | 0.00% | Add +115.2% | 24,136 | $181K |
| Goldman Sachs Group Inc. | 0.00% | New | 23,965 | $180K |
| Citadel Advisors | 0.00% | Add +32.8% | 15,647 | $117K |
| Renaissance Technologies | 0.00% | Reduce -43.2% | 13,400 | $101K |
| Hudson Bay Capital Management LP | 0.00% | New | 13,061 | $98K |
| Private Advisor Group, LLC | 0.00% | No change | 10,416 | $78K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 5,000 | $38K |
| UBS Group AG | 0.00% | Add +8.4% | 2,941 | $22K |
| ORG Partners LLC | 0.00% | No change | 450 | $3K |
| Bank of America Corp. | 0.00% | Reduce -24.9% | 335 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -59.9% | 250 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 185 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 154 | $1K |
| BNP Paribas Financial Markets | 0.00% | No change | 30 | $225 |
| Piscataqua Savings Bank | 0.00% | No change | 25 | $187 |
| Albion Financial Group | 0.00% | No change | 7 | $53 |
| Citigroup Inc. | 0.00% | New | 1 | $8 |
| Global Retirement Partners, LLC | 0.00% | No change | 1 | $8 |
| Motiv8 Investments LLC | 0.00% | New | 10 | $0 |
"% of holder's portfolio" is IMDX's weight in each manager's 13F, not the share of Insight Molecular Diagnostic the manager owns.